Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

MVASI DIN 02470748

Status: Marketed
Holder: AMGEN CANADA INC
Molecule: BEVACIZUMAB
Available to quote

Health Canada record

Active ingredient(s)BEVACIZUMAB 25 MG
Dosage formSolution
RouteIntravenous
ScheduleSCHEDULE D; PRESCRIPTION
ClassHuman
ATCL01FG01 BEVACIZUMAB
Original market date01-Aug-2019
Current status date01-Aug-2019
SourceHealth Canada DPD

Establishment licence of the holder

Amgen Canada Inc — licence 100048, currently licensed, last inspection rating C (2023-03-01).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing BEVACIZUMAB

DINProductCompanyFormStrengthStatus
02522160ABEVMYBIOCON BIOLOGICS CANADA INCSolutionBEVACIZUMAB 400 MGMarketed
02522179ABEVMYBIOCON BIOLOGICS CANADA INCSolutionBEVACIZUMAB 100 MGMarketed
02270994AVASTINHOFFMANN-LA ROCHE LIMITEDSolutionBEVACIZUMAB 25 MGMarketed
02522829AYBINTIOSAMSUNG BIOEPIS CO., LTDSolutionBEVACIZUMAB 100 MGMarketed
02522837AYBINTIOSAMSUNG BIOEPIS CO., LTDSolutionBEVACIZUMAB 400 MGMarketed
02520729BAMBEVIAPOTEX INCSolutionBEVACIZUMAB 100 MGMarketed
02520737BAMBEVIAPOTEX INCSolutionBEVACIZUMAB 400 MGMarketed
02567865BEVQOLVACURATEQ BIOLOGICS PRIVATE LIMITEDSolutionBEVACIZUMAB 400 MGApproved
02567830BEVQOLVACURATEQ BIOLOGICS PRIVATE LIMITEDSolutionBEVACIZUMAB 100 MGApproved
02470756MVASIAMGEN CANADA INCSolutionBEVACIZUMAB 25 MGMarketed
02534177VEGZELMACELLTRION INC.SolutionBEVACIZUMAB 100 MGMarketed
02534185VEGZELMACELLTRION INC.SolutionBEVACIZUMAB 400 MGMarketed
02489430ZIRABEVPFIZER CANADA ULCSolutionBEVACIZUMAB 100 MGMarketed
02489449ZIRABEVPFIZER CANADA ULCSolutionBEVACIZUMAB 400 MGMarketed

Notices of Compliance

NOCDateSubmissionReason
207992018-04-30New Drug Submission (NDS)
Request a quote for MVASI

How to read a Canadian DIN record